Publicaciones en colaboración con investigadores/as de Universidad del País Vasco/Euskal Herriko Unibertsitatea (48)

2024

  1. Serological Antibodies against Kidney, Liver, and Spleen Membrane Antigens as Potential Biomarkers in Patients with Immune Disorders

    International Journal of Molecular Sciences, Vol. 25, Núm. 4

2023

  1. Efficacy of invasive and non-invasive methods for the treatment of Parkinson's disease: Nanodelivery and enriched environment

    International Review of Neurobiology (Academic Press Inc.), pp. 103-143

  2. Review of Technological Challenges in Personalised Medicine and Early Diagnosis of Neurodegenerative Disorders

    International Journal of Molecular Sciences, Vol. 24, Núm. 4

  3. Sexual differences in locus coeruleus neurons and related behavior in C57BL/6J mice

    Biology of Sex Differences, Vol. 14, Núm. 1

  4. Targeting parvalbumin-expressing neurons in the substantia nigra pars reticulata restores motor function in parkinsonian mice

    Cell Reports, Vol. 42, Núm. 10

2022

  1. Dopamine D4 receptor is a regulator of morphine-induced plasticity in the rat dorsal striatum

    Cells, Vol. 11, Núm. 1

  2. Identification of potentially irritating intravenous medications

    Enfermeria Intensiva, Vol. 33, Núm. 3, pp. 132-140

  3. Motor cortico-nigral and cortico-entopeduncular information transmission and its modulation by buspirone in control and after dopaminergic denervation

    Frontiers in Pharmacology, Vol. 13

2021

  1. Study of tissue-specific reactive oxygen species formation by cell membrane microarrays for the characterization of bioactive compounds

    Membranes, Vol. 11, Núm. 12

  2. The effect of 5-HT1A receptor agonists on the entopeduncular nucleus is modified in 6-hydroxydopamine-lesioned rats

    British Journal of Pharmacology, Vol. 178, Núm. 12, pp. 2516-2532

  3. Transfer of SCN1A to the brain of adolescent mouse model of Dravet syndrome improves epileptic, motor, and behavioral manifestations

    Molecular Therapy - Nucleic Acids, Vol. 25, pp. 585-602

2020

  1. 6-Hydroxydopamine lesion and levodopa treatment modify the effect of buspirone in the substantia nigra pars reticulata

    British Journal of Pharmacology, Vol. 177, Núm. 17, pp. 3957-3974

  2. Changes in Day/Night Activity in the 6-OHDA-Induced Experimental Model of Parkinson’s Disease: Exploring Prodromal Biomarkers

    Frontiers in Neuroscience, Vol. 14

  3. Current Techniques for Investigating the Brain Extracellular Space

    Frontiers in Neuroscience, Vol. 14

  4. Editorial: Non-Dopaminergic Systems in Parkinson’s Disease

    Frontiers in Pharmacology

  5. The Noradrenergic System in Parkinson’s Disease

    Frontiers in Pharmacology, Vol. 11

2019

  1. Acute L-DOPA administration reverses changes in firing pattern and low frequency oscillatory activity in the entopeduncular nucleus from long term L-DOPA treated 6-OHDA-lesioned rats

    Experimental Neurology, Vol. 322

  2. Cellular and Synaptic Dysfunctions in Parkinson's Disease: Stepping out of the Striatum

    Cells, Vol. 8, Núm. 9

  3. Dysfunction of serotonergic neurons in Parkinson's disease and dyskinesia

    International Review of Neurobiology (Academic Press Inc.), pp. 259-279

  4. Effects of adult enriched environment on cognition, hippocampal-prefrontal plasticity and NMDAR subunit expression in MK-801-induced schizophrenia model

    European Neuropsychopharmacology, Vol. 29, Núm. 5, pp. 590-600